Only 2 are in the Magnificent Seven

Only 2 are in the Magnificent Seven

It was a big rebound year for stocks. The S & P 500 gained 24%, while the Dow rose 14% and the tech-heavy Nasdaq rose more than 43%. All three major averages were coming off big losses in 2022. Our portfolio of 33 stocks also bounced back. Throughout the year, we held onto our conviction … Read more

Companies losing pricing power after years of unbridled spending

Companies losing pricing power after years of unbridled spending

Pedestrians carrying Nike and Allbirds shopping bags in the SoHo neighborhood of New York on Oct. 24, 2021. Nina Westervelt | Bloomberg | Getty Images After years of unbridled consumer spending on everything from home improvement to dream vacations, some companies are now finding the limits of their pricing power. Shipping giant FedEx last week … Read more

Stoxx 600 gains, S&P 500 chases high

Stoxx 600 gains, S&P 500 chases high

LONDON — European stocks started the final session of 2023 higher, marking a positive end to a solid year. The regional Stoxx 600 index was up 0.18% shortly after the open, with all sectors in the green except oil and gas, which slipped 0.2%. Thin trade is expected, while London markets close early. The blue-chip … Read more

Will the S&P end 2023 on a record high?

Will the S&P end 2023 on a record high?

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., December 1, 2023. Brendan Mcdermid | Reuters This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they … Read more

Investors in 2024 – A New CNBC Delivering Alpha Stock Survey

Investors in 2024 – A New CNBC Delivering Alpha Stock Survey

A Christmas tree stands in front of the New York Stock Exchange (NYSE) in New York on December 1, 2023. Angela Weiss | Afp | Getty Images In the final CNBC’s Delivering Alpha Stock Survey poll of the year, the 300 investors, traders and money managers surveyed are behind Jerome Powell and the Federal Reserve.  … Read more

Global stocks search for new highs

Global stocks search for new highs

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, November 13, 2023. Staff | Reuters LONDON — European stocks were little changed on Thursday as global markets search for new record highs to close out the year. The pan-European Stoxx 600 index hovered around the flatline after an … Read more

Stock Markets: Markets’ holiday cheer continues

Stock Markets: Markets’ holiday cheer continues

Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City. Spencer Platt | Getty Images News | Getty Images This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings … Read more

Obesity and Alzheimer’s drugs pack one-two punch to lift Eli Lilly

Obesity and Alzheimer’s drugs pack one-two punch to lift Eli Lilly

Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer … Read more

Stock Markets: Inflation mission accomplished?

Stock Markets: Inflation mission accomplished?

A customer shops for milk at a grocery store on December 12, 2023 in San Anselmo, California.  Justin Sullivan | Getty Images News | Getty Images This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter … Read more

Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly

Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss pill, danuglipron, after patients in a mid-stage trial experienced … Read more